CN1751129B - 利用基因表达图谱鉴定、监测和治疗传染病和表征传染病相关炎症 - Google Patents

利用基因表达图谱鉴定、监测和治疗传染病和表征传染病相关炎症 Download PDF

Info

Publication number
CN1751129B
CN1751129B CN200380109850.5A CN200380109850A CN1751129B CN 1751129 B CN1751129 B CN 1751129B CN 200380109850 A CN200380109850 A CN 200380109850A CN 1751129 B CN1751129 B CN 1751129B
Authority
CN
China
Prior art keywords
data set
sample
subject
components
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN200380109850.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN1751129A (zh
Inventor
M·贝维拉卡
V·特赖恩
D·M·班凯蒂斯－戴维斯
J·C·舍罗丽斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of CN1751129A publication Critical patent/CN1751129A/zh
Application granted granted Critical
Publication of CN1751129B publication Critical patent/CN1751129B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN200380109850.5A 2002-12-19 2003-12-19 利用基因表达图谱鉴定、监测和治疗传染病和表征传染病相关炎症 Expired - Lifetime CN1751129B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43525702P 2002-12-19 2002-12-19
US60/435,257 2002-12-19
PCT/US2003/040551 WO2004057034A1 (en) 2002-12-19 2003-12-19 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles

Publications (2)

Publication Number Publication Date
CN1751129A CN1751129A (zh) 2006-03-22
CN1751129B true CN1751129B (zh) 2014-07-23

Family

ID=32682206

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200380109850.5A Expired - Lifetime CN1751129B (zh) 2002-12-19 2003-12-19 利用基因表达图谱鉴定、监测和治疗传染病和表征传染病相关炎症

Country Status (8)

Country Link
EP (1) EP1579008A1 (https=)
JP (2) JP2006510382A (https=)
CN (1) CN1751129B (https=)
AU (1) AU2003303238B2 (https=)
BR (1) BR0317612A (https=)
CA (1) CA2511237A1 (https=)
MX (1) MXPA05006804A (https=)
WO (1) WO2004057034A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316232A (pt) 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
EP2128270B1 (en) 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
EP1945814A2 (en) * 2005-09-27 2008-07-23 Source MDX Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
CA2652239A1 (en) * 2006-05-16 2007-11-29 Source Mdx Assessment of effect of an agent on a human biological condition using rodent gene expression panels
US20100267575A1 (en) * 2006-10-17 2010-10-21 Childrens Hospital Medical Center Gene array technique for predicting response in inflammatory bowel diseases
DE102007036678B4 (de) * 2007-08-03 2015-05-21 Sirs-Lab Gmbh Verwendung von Polynukleotiden zur Erfassung von Genaktivitäten für die Unterscheidung zwischen lokaler und systemischer Infektion
RU2612884C2 (ru) * 2010-04-02 2017-03-13 Курна, Инк. Лечение заболеваний, связанных с колониестимулирующим фактором 3 (csf3), путем ингибирования природного антисмыслового транскрипта k csf3
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
CN107710207B (zh) * 2015-03-12 2022-03-08 皇家飞利浦有限公司 感染管理和控制
US11031119B2 (en) * 2019-11-13 2021-06-08 Cube Click, Inc. Dental images processed with deep learning for national security
CN118824376B (zh) * 2024-09-18 2025-01-21 江苏省疾病预防控制中心(江苏省预防医学科学院) 基于元学习技术的呼吸系统传染病人工智能辅助筛查系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024935A1 (en) * 1996-12-06 1998-06-11 Urocor, Inc. Diagnosis of disease state using mrna profiles
CA2378008A1 (en) * 1999-06-28 2001-04-12 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles
US6964850B2 (en) * 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

Also Published As

Publication number Publication date
CA2511237A1 (en) 2004-07-08
AU2003303238B2 (en) 2010-07-22
BR0317612A (pt) 2005-12-06
AU2003303238A1 (en) 2004-07-14
MXPA05006804A (es) 2006-03-30
JP2010227111A (ja) 2010-10-14
WO2004057034A1 (en) 2004-07-08
CN1751129A (zh) 2006-03-22
EP1579008A1 (en) 2005-09-28
JP2006510382A (ja) 2006-03-30

Similar Documents

Publication Publication Date Title
CN102402650A (zh) 利用基因表达分布图识别、监控和治疗疾病以及鉴定生物学状态
JP2010227111A (ja) 遺伝子発現プロフィールを用いる、感染症の同定、モニタリング、および処置、ならびに感染症に関連する炎症状態の特徴付け
AU784233B2 (en) Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles
US20080233573A1 (en) Gene expression profiling for identification, monitoring and treatment of transplant rejection
WO2007038754A2 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
AU2015334840A1 (en) Assessment of TGF-beta cellular signaling pathway activity using mathematical modelling of target gene expression
JP2020535823A (ja) 標的遺伝子発現の数学的モデル化を使用する、ｊａｋ−ｓｔａｔ３細胞シグナル伝達経路活性の評価
US20110306512A1 (en) Gene Expression Profiling for Identification, Monitoring, and Treatment of Osteoarthritis
AU2003303238A2 (en) Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles
JP2006510382A5 (https=)
WO2008091708A2 (en) Gene expression profiling for identification, monitoring, and treatment of lupus erythematosus
CN105506074B (zh) 一种用于精神分裂症诊断的lncRNA标志物及试剂盒
EP2069533A2 (en) Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
WO2007136728A2 (en) Assessment of effect of an agent on a human biological condition using rodent gene expression panels
US20230071390A1 (en) Assessment of pr cellular signaling pathway activity using mathematical modelling of target gene expression
WO2006138561A2 (en) Gene expression profiling for identification and monitoring of multiple sclerosis
McCoy The Genetics of Kidney Disorders in Phelan-McDermid Syndrome
HK1169190A (en) Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
CN113817812A (zh) 一种蛋白酶基因甲基化作为脑卒中早期诊断的潜在标志物
Tsai CSTB and FABP5 serum mRNA differentiate histologically active and inactive patients with eosinophilic esophagitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060322

ASS Succession or assignment of patent right

Owner name: LIFE TECHNOLOGIES CORPORATION

Free format text: FORMER OWNER: SOURCE PREC MEDICINE INC.

Effective date: 20120105

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20120105

Address after: California, USA

Applicant after: LIFE TECHNOLOGIES Corp.

Address before: American Colorado

Applicant before: Source Precision Medicine, Inc.

CI01 Publication of corrected invention patent application

Correction item: Rejection of patent application

Correct: Dismiss

False: Reject

Number: 31

Volume: 26

ERR Gazette correction

Free format text: CORRECT: PATENT APPLICATION REJECTION OF AFTER PUBLICATION; FROM: REJECTION TO: REVOCATION REJECTED

C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20140723